Research from the past decade suggests that sigma-1 receptors and their encoding gene, SIGMAR1, together act as a therapeutic target for patients with dementia.
Will Pass, DVM
Advertisement
Articles by Will Pass, DVM
Advertisement
Latest Updated Articles
Sigma-1 Agonists Offer Combination Approach to Dementia SymptomsPublished: April 23rd 2019 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Earlier Initiation of Pimavanserin Leads to Better Improvement of Parkinson Disease Psychosis Symptoms
2
MDS Congress 2025: Top Expert Interviews and Key Takeaways
3
A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential
4
Increasing Early Awareness of Child Neurology as a Potential Career Path: Miya Bernson-Leung, MD, EdM
5
